Total Payments
$99,563
2024 Payments
$22,803
Companies
15
Transactions
97
Medicare Patients
284
Medicare Billing
$53,691
Payment Breakdown by Category
Consulting$59,260 (59.5%)
Research$32,292 (32.4%)
Travel$4,293 (4.3%)
Food & Beverage$3,294 (3.3%)
Other$350.00 (0.4%)
Education$73.95 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $59,260 | 23 | 59.5% |
| Unspecified | $32,292 | 4 | 32.4% |
| Travel and Lodging | $4,293 | 18 | 4.3% |
| Food and Beverage | $3,294 | 50 | 3.3% |
| Grant | $350.00 | 1 | 0.4% |
| Education | $73.95 | 1 | 0.1% |
Payments by Type
General
$67,271
93 transactions
Research
$32,292
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eli Lilly and Company | $32,292 | 4 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $29,468 | 33 | $0 (2024) |
| Gilead Sciences, Inc. | $13,341 | 17 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $11,036 | 9 | $0 (2024) |
| Daiichi Sankyo Inc. | $10,369 | 15 | $0 (2022) |
| Stemline Therapeutics Inc. | $2,047 | 2 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $212.03 | 3 | $0 (2018) |
| Lilly USA, LLC | $184.96 | 3 | $0 (2019) |
| Janssen Biotech, Inc. | $168.89 | 2 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $124.91 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $22,803 | 27 | AstraZeneca Pharmaceuticals LP ($9,744) |
| 2023 | $24,738 | 31 | AstraZeneca Pharmaceuticals LP ($14,795) |
| 2022 | $47,236 | 21 | Eli Lilly and Company ($31,892) |
| 2021 | $3,914 | 3 | Novartis Pharmaceuticals Corporation ($3,760) |
| 2019 | $79.34 | 2 | Lilly USA, LLC ($79.34) |
| 2018 | $671.94 | 11 | Janssen Scientific Affairs, LLC ($212.03) |
| 2017 | $121.43 | 2 | Lilly USA, LLC ($105.62) |
All Payment Transactions
97 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $16.00 | General |
| 12/10/2024 | Novartis Pharmaceuticals Corporation | — | Consulting Fee | Cash or cash equivalent | $2,100.00 | General |
| 12/10/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $75.00 | General |
| 11/07/2024 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $55.48 | General |
| Category: ONC | ||||||
| 10/17/2024 | Gilead Sciences, Inc. | Trodelvy (Drug) | Consulting Fee | Cash or cash equivalent | $5,690.00 | General |
| Category: ONC | ||||||
| 10/17/2024 | Gilead Sciences, Inc. | Trodelvy (Drug) | Travel and Lodging | In-kind items and services | $707.95 | General |
| Category: ONC | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $685.00 | General |
| 10/17/2024 | Gilead Sciences, Inc. | Trodelvy (Drug) | Travel and Lodging | In-kind items and services | $80.00 | General |
| Category: ONC | ||||||
| 10/17/2024 | Gilead Sciences, Inc. | Trodelvy (Drug) | Travel and Lodging | In-kind items and services | $28.14 | General |
| Category: ONC | ||||||
| 10/12/2024 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $59.96 | General |
| Category: ONC | ||||||
| 10/12/2024 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $56.65 | General |
| Category: ONC | ||||||
| 10/12/2024 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $56.65 | General |
| Category: ONC | ||||||
| 10/11/2024 | Gilead Sciences, Inc. | Trodelvy (Drug) | Travel and Lodging | In-kind items and services | $303.97 | General |
| Category: ONC | ||||||
| 09/13/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Consulting Fee | Cash or cash equivalent | $1,950.00 | General |
| Category: Oncology | ||||||
| 09/06/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $7,535.00 | General |
| 09/02/2024 | AstraZeneca Pharmaceuticals LP | — | Travel and Lodging | Cash or cash equivalent | $145.91 | General |
| 09/02/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | Cash or cash equivalent | $31.72 | General |
| 08/24/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $97.01 | General |
| Category: Oncology | ||||||
| 07/01/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $685.00 | General |
| 06/14/2024 | TerSera Therapeutics LLC | Zoladex (Drug) | Food and Beverage | In-kind items and services | $82.61 | General |
| Category: Oncology | ||||||
| 06/02/2024 | Novartis Pharmaceuticals Corporation | — | Consulting Fee | Cash or cash equivalent | $1,575.00 | General |
| 06/02/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $140.94 | General |
| 05/31/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $116.44 | General |
| 02/24/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $50.04 | General |
| 02/21/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $103.13 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A PHASE 1A/1B STUDY OF LY3484356 ADMINISTERED AS MONOTHERAPY AND IN COMBINATION WITH ABEMACICLIB TO PATIENTS WITH ER+, HER2- LOCALLY ADVANCED OR METASTATIC BREAST CANCER | Eli Lilly and Company | $31,992 | 3 |
| A PHASE 1A/1B STUDY OF LY3484356 ADMINISTERED AS MONOTHERAPY AND IN COMBINATION WITH ABEMACICLIB TO PATIENTS WITH ER+ HER2- LOCALLY ADVANCED OR METASTATIC BREAST CANCER | Eli Lilly and Company | $300.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 87 | 188 | $80,190 | $18,704 |
| 2022 | 4 | 95 | 203 | $79,074 | $18,486 |
| 2021 | 5 | 80 | 157 | $52,188 | $13,418 |
| 2020 | 1 | 22 | 22 | $7,888 | $3,084 |
Total Patients
284
Total Services
570
Medicare Billing
$53,691
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 48 | 146 | $62,634 | $15,379 | 24.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 14 | 14 | $8,652 | $1,764 | 20.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 25 | 28 | $8,904 | $1,561 | 17.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 32 | 113 | $48,477 | $11,510 | 23.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 31 | 43 | $13,674 | $2,993 | 21.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 20 | 20 | $12,360 | $2,541 | 20.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 12 | 27 | $4,563 | $1,441 | 31.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 21 | 53 | $22,737 | $5,731 | 25.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 12 | 35 | $9,660 | $2,736 | 28.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 18 | 18 | $11,124 | $2,503 | 22.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 14 | 35 | $5,915 | $1,631 | 27.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 15 | 16 | $2,752 | $816.00 | 29.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 22 | 22 | $7,888 | $3,084 | 39.1% |
About Dr. Sonya Reid, MD
Dr. Sonya Reid, MD is a Hospitalist healthcare provider based in Nashville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/23/2013. The National Provider Identifier (NPI) number assigned to this provider is 1457795239.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sonya Reid, MD has received a total of $99,563 in payments from pharmaceutical and medical device companies, with $22,803 received in 2024. These payments were reported across 97 transactions from 15 companies. The most common payment nature is "Consulting Fee" ($59,260).
As a Medicare-enrolled provider, Reid has provided services to 284 Medicare beneficiaries, totaling 570 services with total Medicare billing of $53,691. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Hospitalist
- Other Specialties Hematology & Oncology, Internal Medicine
- Location Nashville, TN
- Active Since 04/23/2013
- Last Updated 08/29/2024
- Taxonomy Code 208M00000X
- Entity Type Individual
- NPI Number 1457795239
Products in Payments
- Trodelvy (Drug) $13,341
- ENHERTU (Biological) $12,673
- ENHERTU (Drug) $10,369
- KISQALI (Drug) $7,145
- Orserdu (Drug) $2,047
- LYNPARZA (Drug) $1,713
- DARZALEX (Biological) $183.07
- KEYTRUDA (Biological) $124.91
- Onivyde (Drug) $124.21
- Erleada (Drug) $123.90
- Zoladex (Drug) $82.61
- VERZENIO (Drug) $79.34
- IMBRUVICA (Drug) $73.95
- CHANTIX (Drug) $17.29
- Neulasta (Biological) $15.81
- EMPLICITI (Biological) $13.71
- MYLOTARG (Biological) $10.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hospitalist Doctors in Nashville
Dr. Olalekan Oluwole, Md, Mph, MD, MPH
Hospitalist — Payments: $219,617
Hospitalist $219,617
Andrew Zurick, M.d, M.D
Hospitalist — Payments: $171,446
Hospitalist $171,446
Christopher Hoffman, Md, MD
Hospitalist — Payments: $43,485
Hospitalist $43,485
Ravi Mishra, Md, MD
Hospitalist — Payments: $6,123
Hospitalist $6,123
Courtney Havill, Fnp-C, FNP-C
Hospitalist — Payments: $3,934
Hospitalist $3,934
Philip Kuo, Md, MD
Hospitalist — Payments: $3,825
Hospitalist $3,825